Gilead: HIV Franchise Woes Highlight Cancer Follies
Gilead’s HIV franchise generated $19.612B in 2024, but faces future funding challenges. Learn why GILD stock is a "Hold" amid ...
Making Progress for People Affected by Liver Disease
The liver is one of the body’s most vital organs, working tirelessly behind the scenes to detoxify, regulate metabolism, ...
‘Handmaid’s Tale’ exec reveals when spinoff ‘The Testaments’ will begin filming – and it’s sooner than you think
The Post caught up with several stars and crew members of “The Handmaid’s Tale” at the show’s sixth and final season premiere ...
Zacks Investment Research on MSN20h
Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note
In the latest market close, Gilead Sciences (GILD) reached $112.39, with a +0.45% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 4.84%. On ...
STAT2d
Rollout of ‘miracle’ HIV prevention drug is threatened by Trump cuts to global AIDS relief program
PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV ...
Zacks Investment Research on MSN2d
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...
Ann Dowd and ‘Handmaid’s Tale’ Team Tease Upcoming Sequel Series ‘The Testaments’
"We tried not to make the same show — it's got younger voices, it's got a completely different feel and a completely ...
CSRWire2d
Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV
Tomas Cihlar knew all too well that despite initial successes with combination treatment, HIV was firmly holding ground ...
Gilead, Regeneron have most theoretical PDUFA date risk, says BofA
With the FDA appearing to be undergoing major disruption under new leadership, BofA analyst Tim Anderson says one way to assess the risk from ...
Winners and wishers: 9 potential Bay Area drug approvals coming this year
Three other Bay Area companies — Mirum Therapeutics Inc. (Nasdaq: MIRM), Soleno Therapeutics Inc. (Nasdaq: SLNO) and Exelixis ...
'The Handmaid's Tale' to continue in new series with Ann Dowd and more
Hulu announced that it is developing a series based on Margaret Atwood's 2019 novel "The Testaments," which is a follow-up to ...
TV review: 'Handmaid's Tale' final season expands Margaret Atwood themes
The final season of "The Handmaid's Tale," premiering April 8 on Hulu, expands the themes and story of Margaret Atwood's ...